How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

225 results for

Athetosis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. (Abstract)

, including chorea (n=4), stereotypic movements (n=4), ataxia (n=3), limb dystonia (n=2), limb myorhythmia (n=2), oromandibular dystonia (n=2), facial myorhythmia, blepharospasm, opisthotonus, athetosis, and tremor (n=1, each). More than a single movement disorder was observed in 6 of these patients. Resolution of the abnormal movements was observed in all patients with immunotherapy; 1 patient improved with tetrabenazine.A wide variety of movement disorders, often in combination, can be observed

2013 Movement Disorders

122. Head drop in Huntington disease: Insights into the pathophysiology. (Abstract)

Head drop in Huntington disease: Insights into the pathophysiology. 23884035 2013 10 24 2013 08 20 1526-632X 81 8 2013 Aug 20 Neurology Neurology Head drop in Huntington disease: insights into the pathophysiology. 769-70 10.1212/WNL.0b013e3182a1aa55 Morgante Francesca F Dipartimento di Neuroscienze, Università di Messina, Italy. fmorgante@gmail.com Girlanda Paolo P Martino Davide D eng Case Reports Journal Article 2013 07 24 United States Neurology 0401060 0028-3878 AIM IM Athetosis diagnosis

2013 Neurology

123. Movement disorders in cerebrovascular disease. (Abstract)

including chorea, ballism, athetosis, dystonia, tremor, myoclonus, stereotypies, and akathisia. Some of these disorders occur immediately after acute stroke, whereas others can develop later, and yet others represent delayed-onset progressive movement disorders. These movement disorders have been encountered in patients with ischaemic and haemorrhagic strokes, subarachnoid haemorrhage, cerebrovascular malformations, and dural arteriovenous fistula affecting the basal ganglia, their connections

2013 Lancet Neurology

124. Huntington's Chorea

dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including

2015 FP Notebook

125. Kernicterus

of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child (...) Neurology, 5th ed, p613) Definition (CSP) brain disorder associated with high levels of bilrubin; clinical features include athetosis, muscle spasticity or hypotonia, impaired vertical gaze, and deafness; nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the blood-brain barrier; this condition occurs primarily in neonates with perinatal blood incompatibilities, but may rarely occur in adults. Concepts Disease or Syndrome ( T047 ) MSH

2015 FP Notebook

126. A Trial Comparing Two Methods of CIMT in the Hemiplegic Child

of bilateral upper limb involvement. Diagnosis/ clinical evidence of athetosis or dystonia. Any medical condition which would cause problems with the cast e.g. chronic eczema. An episode of >2 weeks of prolonged CIMT using a cast /splint in the previous 6 months. Contacts and Locations Go to No Contacts or Locations Provided More Information Go to Layout table for additonal information Responsible Party: Pauline Christmas, Consultant Physiotherapist, University of Birmingham ClinicalTrials.gov Identifier

2012 Clinical Trials

127. Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy

Exclusion Criteria: Children who have a diagnosis of "mixed" types of CP (i.e. athetosis) or other movement disorders (i.e. ataxia) Children who have had a selective dorsal rhizotomy, are presently are receiving intrathecal Baclofen, or have changed their spasticity medications in the past 6 months. Children who have a metallic or electrical implants Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study

2012 Clinical Trials

128. Exploring Hypertonia in Children With Cerebral Palsy

it is often overlooked in the diagnostic formulation of motor aspects of cerebral palsy, and therefore does not necessarily figure in treatment decision-making. Under-recognised dystonia, when co-existent with spasticity, can produce unpredictable surgical outcomes in the management of gait disorders and associated musculoskeletal deformities. In addition, other abnormal movements such as chorea and athetosis may be observed in these children, adding to the complexity of the movement disorder (...) (dystonia or athetosis) and 3.6% as ataxic.1 However this study also found that when children were assessed face-to-face by a group of expert paediatricians, 19.4% of the population was noted on observation alone to have abnormal movements, which included dyskinesias. This increased with motor severity by Gross Motor Functional Classification System (GMFCS) from 7% (level I) to 45% (level V). We questioned whether in fact recognition of some dyskinesias are "masked" by the presence of spasticity

2012 Clinical Trials

129. Brainstem cavernous malformations: the role of Gamma Knife surgery. Full Text available with Trip Pro

patients experienced at least 2 instances of repeated bleeding before GKS; these hemorrhages caused neurological deficits including cranial nerve deficits, hemiparesis, hemisensory deficits, spasticity, chorea or athetosis, and consciousness disturbance.The mean size of the CMs at the time of GKS was 3.2 cm(3) (range 0.1-14.6 cm(3)). The mean radiation dose directed to the lesion was 11 Gy with an isodose level at 60.0%. The mean clinical and imaging follow-up time was 40.6 months (range 1.0-150.7

2012 Journal of Neurosurgery

130. Infantile Cerebellar-Retinal Degeneration Associated with a Mutation in Mitochondrial Aconitase, ACO2. Full Text available with Trip Pro

Infantile Cerebellar-Retinal Degeneration Associated with a Mutation in Mitochondrial Aconitase, ACO2. Degeneration of the cerebrum, cerebellum, and retina in infancy is part of the clinical spectrum of lysosomal storage disorders, mitochondrial respiratory chain defects, carbohydrate glycosylation defects, and infantile neuroaxonal dystrophy. We studied eight individuals from two unrelated families who presented at 2-6 months of age with truncal hypotonia and athetosis, seizure disorder

2012 American Journal of Human Genetics

131. Further evidence of validity of the Modified Melbourne Assessment for neurologically impaired children aged 2 to 4 years. Full Text available with Trip Pro

behaviours for task and time demands on both tools, and (3) scores on the MMA could discriminate between children with mild, moderate, and severe levels of upper limb impairment.  An observational study of 30 children (19 males, 11 females) with neurological impairment aged 2 to 4 years. Twenty-four children had spasticity (20 with a unilateral and four with a bilateral impairment) and two children presented with athetosis, two with ataxia, and two with hypotonia.A high, positive relation was found

2012 Developmental Medicine and Child Neurology

132. L-dopa in postencephalitic parkinsonism. (Abstract)

L-dopa in postencephalitic parkinsonism. 4180215 1969 05 02 2017 09 20 0140-6736 1 7598 1969 Apr 12 Lancet (London, England) Lancet L-dopa in postencephalitic parkinsonism. 744-6 Calne D B DB Stern G M GM Laurence D R DR Sharkey J J Armitage P P eng Clinical Trial Journal Article Randomized Controlled Trial England Lancet 2985213R 0140-6736 0 Placebos 63-84-3 Dihydroxyphenylalanine AIM IM Aged Athetosis chemically induced Chorea chemically induced Clinical Trials as Topic Delusions chemically

1969 Lancet (London, England) Controlled trial quality: uncertain

133. On “Athetosis” and Post-Hemiplegic Disorders of Movement Full Text available with Trip Pro

On “Athetosis” and Post-Hemiplegic Disorders of Movement 20896465 2011 03 29 2011 03 29 0959-5287 59 1876 Medico-chirurgical transactions Med Chir Trans On "Athetosis" and Post-Hemiplegic Disorders of Movement. 271-326.1 Gowers W R WR eng Journal Article England Med Chir Trans 0156105 0959-5287 2010 10 5 6 0 1876 1 1 0 0 1876 1 1 0 1 ppublish 20896465 PMC2150275

1876 Medico-chirurgical transactions

134. Treatment of involuntary movement disorders with tetrabenazine. Full Text available with Trip Pro

had Huntington's chorea, two athetosis, two dystonia musculorum deformans, one hemiballismus, and one spasmodic torticollis. Four of the eight improved patients have continued taking the drug for longer than six months. In a second study seven patients with Huntington's chorea were treated for two weeks each with tetrabenazine (50 mg t.d.s.) and with amantadine (100 mg t.d.s.) and the results assessed by the same method. The choreiform movements of six of these patients were strikingly improved (...) with tetrabenazine therapy, but amantadine had no effect. Tetrabenazine is an effective agent for the suppression of choreiform and ballistic involuntary movements. It is only slightly effective in the treatment of athetosis and spasmodic torticollis. Drowsiness, insomnia, and depression were the most conspicuous unwanted effects, and these may limit the clinical usefulness of the drug.

1972 Journal of neurology, neurosurgery, and psychiatry

135. Current Concepts of Hyperuricemia and Gout Full Text available with Trip Pro

retardation, choreo-athetosis, aggressive behavior, lip-biting and self-mutilation and associated with decidedly increased purine biosynthesis serves as a prototype of this kind of disorder. Other defects in regulation of purine biosynthesis have been postulated but their existence not yet confirmed. It has been demonstrated that urate crystals which are deposited from hyperuricemic body fluids set up an acute inflammatory reaction by means of a variety of chemical mediators. Thus, acute gouty arthritis

1969 California Medicine

136. Involuntary movements in multiple sclerosis. Full Text available with Trip Pro

Involuntary movements in multiple sclerosis. 4297774 1968 08 07 2018 11 13 0007-1447 2 5607 1968 Jun 22 British medical journal Br Med J Involuntary movements in multiple sclerosis. 738-40 Sarkari N B NB eng Journal Article England Br Med J 0372673 0007-1447 9002-60-2 Adrenocorticotropic Hormone AIM IM Adrenocorticotropic Hormone therapeutic use Adult Athetosis etiology Chorea etiology Female Humans Male Middle Aged Multiple Sclerosis cerebrospinal fluid complications drug therapy 1968 6 22

1968 British medical journal

137. PROGRESSIVE FAMILIAL CHOREOATHETOSIS WITH CUTANEOUS TELANGIECTASIA Full Text available with Trip Pro

PROGRESSIVE FAMILIAL CHOREOATHETOSIS WITH CUTANEOUS TELANGIECTASIA 13429376 2002 05 01 2018 12 01 0022-3050 20 2 1957 May Journal of neurology, neurosurgery, and psychiatry J. Neurol. Neurosurg. Psychiatry Progressive familial choreoathetosis with cutaneous telangiectasia. 98-104 WELLS C E CE SHY G M GM eng Case Reports Journal Article England J Neurol Neurosurg Psychiatry 2985191R 0022-3050 OM Athetosis Chorea Humans Medical Records Telangiectasis 5732:27556 ATHETOSIS/case reports CHOREA/case

1957 Journal of neurology, neurosurgery, and psychiatry

138. Athetoid movements in cervical spondylosis. Full Text available with Trip Pro

Athetoid movements in cervical spondylosis. 5427424 1970 08 26 2008 11 20 0003-4967 29 2 1970 Mar Annals of the rheumatic diseases Ann. Rheum. Dis. Athetoid movements in cervical spondylosis. 195 Bickerstaff E R ER eng Journal Article England Ann Rheum Dis 0372355 0003-4967 IM Arm innervation Athetosis complications Cervical Vertebrae Humans Spinal Diseases complications 1970 3 1 1970 3 1 0 1 1970 3 1 0 0 ppublish 5427424 PMC1010541

1970 Annals of the Rheumatic Diseases

139. Three Cases of “Bilateral Athetosis.” Full Text available with Trip Pro

Three Cases of “Bilateral Athetosis.” 19976071 2010 06 24 2010 06 24 0035-9157 5 Neurol Sect 1912 Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Three Cases of "Bilateral Athetosis.". 60-2 Collier J J eng Journal Article England Proc R Soc Med 7505890 0035-9157 2009 12 9 6 0 1912 1 1 0 0 1912 1 1 0 1 ppublish 19976071 PMC2005486

1912 Proceedings of the Royal Society of Medicine

140. Chronic manganese poisoning in the dry battery industry Full Text available with Trip Pro

Chronic manganese poisoning in the dry battery industry 5101169 1971 04 01 2018 11 13 0007-1072 28 1 1971 Jan British journal of industrial medicine Br J Ind Med Chronic manganese poisoning in the dry battery industry. 78-82 Emara A M AM el-Ghawabi S H SH Madkour O I OI el-Samra G H GH eng Journal Article England Br J Ind Med 0370637 0007-1072 IM Adult Air analysis Athetosis chemically induced Chorea chemically induced Chronic Disease Humans 1971 1 1 1971 1 1 0 1 1971 1 1 0 0 ppublish 5101169

1971 British Journal of Industrial Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>